Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indivina continuous combined regimens for postmenopausal vasomotor symptoms
2004-000053-34Phase 3Completed
- Sponsor
- Orion Corporation
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol valerate + medroxyprogesterone acetate in vasomotor symptoms and Hypoestrogenemia (3 arms), sponsored by Orion Corporation. Started Oct 2004; status: completed.
02
Drugs
estradiol valerate + medroxyprogesterone acetate
03
Conditions
vasomotor symptomsHypoestrogenemia
Beyond the preview
Go deeper on 2004-000053-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000053-34.